All Type of News
Ailments by Seasonal and Regional Characteristics Identified
According to the statistical analysis released by the National Health Insurance Corporation (NHIC) on the historical treatment records by season, acute bronchitis was the most frequent for winter, spring and fall, whi...
Zelmac Approved for Chronic Idiopathic Constipation by KFDA
Novartis Korea announced on February 28th that the Korea Food and Drug Administration (KFDA) gave approval for a supplemental indication for its pro-motility drug Zelmac (active ingredient: tegaserod) for the treatmen...
Choongwae with Export Sales Growth Prospect
From a recent market analysis on the domestic pharmaceutical firms released by Hanyang Securities, Choongwae Pharma is selected as the top prospect for its international growth potential for the current year and forwa...
New Industry Standards for Bioequivalence Testing on 43 Ingredients
The Korea Food and Drug Administration (KFDA) recently released the standard bioequivalence testing guidance on 43 pharmaceutical active ingredients, including gabapentin, glimepiride, rebamipide, and cefroxidine, amo...
Pharmacists Make Recommendations to President
In a letter of recommendation addressed to the nation's president, the Korea Pharmaceutical Association (KPA) asked President Roh for his consideration towards an expedited regulatory measure on the introduction of si...
226 Drugs with Reduced National Health Insurance Pricing
The average reduction of National Health Insurance (NHI) medication price is determined at 6.3%, based on the post-marketing insurance price review conducted by the Ministry of Health and Welfare (MOHW) on 749 drugs l...
More People Quit Smoking after Recent Cigarette Price Increase
Results from a representative survey conducted by the Ministry of Health and Welfare (MOHW) indicate that 8.3% of adult male smokers have quitted smoking since last year, and the majority of them expressed that their ...
KPA Aims to Establish Fair Sales Practice of OTC Medications
The Korea Pharmaceutical Association (KPA) recently announced of its nationwide campaign effort to promote a fair trade practice involving the sale of over-the-counter (OTC) medications at retail pharmacies.
The an...
Phased Rollout of Bioequivalence Testing Requirement Suggested
The Regulatory Reform Committee released on February 25th of its review details and recommendations on various amendment proposals to the Korea Pharmaceutical Affairs Law, covering the major areas such as bioequivalen...
Maxmavil, Amlodipin Receive Korea New Drug Awards
The Korea Drug Research Association (KDRA) selected Maxmavil by Yuyu Inc. and Amlodipin by Hanmi Pharmaceutical as the Korea New Drug Award recipients, where the award ceremony was held last week at the Seoul National...
